Results of search for 'au:"Orquiza, Michael"' › MedStar Authors Catalog catalog

Results
	1.	Evaluation of lithium as adjunctive treatment of 131I therapy for differentiated thyroid cancer: an educational exhibit MedStar authors: Khorjekar, Gauri Orquiza, Michael D Van Nostrand, Douglas Wartofsky, Leonard Year: 2013 Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Orquiza M, Van Nostrand D, Khorjekar G, Elboga U, Guan H, Wartofsky L Local accession number: 2013_7 Add to cart (remove)
	2.	Whole body retention of I-131 at 24hr vs. 48hr as a predictor of maximum tolerated activity (MTA). MedStar authors: Atkins, Frank Orquiza, Michael D Van Nostrand, Douglas Wartofsky, Leonard Year: 2013 Citation: 2013/06/08/ Department: Department of Medicine/Endocrinology Department of Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Atkins F, Van Nostrand D, Orquiza M, Wartofsky L Local accession number: 2013_158 Add to cart (remove)
	3.	Whole body retention of 131I at 24hr versus 48hr as a predictor of maximum tolerated activity (MTA). MedStar authors: Atkins, Frank Orquiza, Michael D Van Nostrand, Douglas Wartofsky, Leonard Year: 2013 Citation: 2013/06/08/ Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Poster Presentation Local accession number: 2013_231 Add to cart (remove)
	4.	Sialoadenitis and xerostomia secondary to I-131 therapy in patients with differentiated thyroid cancer and who took sialagogues: a prospective study. MedStar authors: Burman, Kenneth D Orquiza, Michael Van Nostrand, Douglas Wartofsky, Leonard Wu, Di Year: 2017 Institution: MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Conference All authors: Burman K Orquiza M Turner D Van Nostrand D Wartofsky L Wu D Local accession number: A2017_576 Add to cart (remove)
	5.	Xerophthalmia and epiphora secondary to 131I therapy in patients with differentiated thyroid cancer: a prospective study. MedStar authors: Burman, Kenneth D Orquiza, Michael Van Nostrand, Douglas Wartofsky, Leonard Wu, Di Year: 2017 Citation: Unpublished 2017/10/18 Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Burman K Orquiza M Turner D Van Nostrand D Wartofsky L Wu D Local accession number: A2017_569 Add to cart (remove)
	6.	The public sites and frequency of detection of patients treated with 131I and the security management of those patients: the final report of a national survey MedStar authors: Bethancourt, E Bikas, A Burman, Kenneth D Orquiza, Michael H Van Nostrand, Douglas Wartofsky, Leonard Year: 2015 Citation: Unpublished 2015 Jun Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Bethancourt E, Van Nostrand D, Orquiza M, Bloom G, Bikas A, Burman k, Wartofsky l Local accession number: 2015_190 Add to cart (remove)
	7.	The frequency and content of documents issued for patients' 131I therapies for security agents: the final report of a national survey MedStar authors: Bethancourt, E Bikas, A Burman, Kenneth D Orquiza, Michael H Van Nostrand, Douglas Wartofsky, Leonard Year: 2015 Citation: Unpublished 2015 Jun Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Bethancourt E, Van Nostrand D, Orquiza M, Bloom G, Bikas A, Burman k, Wartofsky l Local accession number: 2015_191 Add to cart (remove)
	8.	Correlation of 124I PET dosimetry with clinical response of 131I therapy (Tx) for metastatic differentiated thyroid cancer (DTC) MedStar authors: Atkins, Frank Garcia, Carlos Khorjekar, Gauri Mete, Mihriye Orquiza, Michael D Van Nostrand, Douglas Wartofsky, Leonard Year: 2013 Institution: MedStar Health Research Institute MedStar Washington Hospital Center Washington Cancer Institute Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Khorjekar G, Senthamizhchelvan S, Hobbs R, Orquiza M, Atkins F, Mete M, Garcia C, Wartofsky L, Sgouros G, Van Nostrand D Local accession number: 2013_4 Add to cart (remove)
	9.	Detection at Public Facilities of 131I in Patients Treated for Differentiated Thyroid Cancer: Frequency, Sites, Management by Security Agents, and Physician Documentation Recommended for Patients. MedStar authors: Bethancourt, Evelyn Bikas, Athanasios Burman, Kenneth D Orquiza, Michael Van Nostrand, Douglas Wartofsky, Leonard Wu, Di PMID: 30361377 Year: 2019 Citation: Journal of Nuclear Medicine. 60(5):638-643, 2019 05. Institution: MedStar Health Research Institute MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Medline publication type: Journal Article Form of publication: Journal Article All authors: Bethancourt E, Bikas A, Bloom G, Burman KD, Orquiza M, Van Nostrand D, Wartofsky L, Wu D DOI: https://dx.doi.org/10.2967/jnumed.118.213256 Add to cart (remove)
	10.	Correlation of 124I PET dosimetry with clinical response of 131I therapy (Tx) for Metastatic Differentiated Thyroid Cancer (DTC). MedStar authors: Atkins, Frank Garcia, Carlos Khorjekar, Gauri Mete, Mihriye Orquiza, Michael D Van Nostrand, Douglas Wartofsky, Leonard Year: 2013 Institution: MedStar Health Research Institute MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Khorjekar G, Orquiza MD, Atkins F, Mete M, Garcia C, Wartofsky L, Van Nostrand D Local accession number: 2013_2 Add to cart (remove)
	11.	Correlation of 124 I PET dosimetry with clinical response of 131 I therapy for metastatic differentiated thyroid cancer. MedStar authors: Atkins, Frank Garcia, Carlos Khorjekar, Gauri Mete, Mihriye Orquiza, Michael D Van Nostrand, Douglas Wartofsky, Leonard Year: 2013 Institution: MedStar Health Research Institute MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Khorjekar G, Senthamizhchelvan S, Hobbs R, Orquiza M, Atkins F, Mete M, Garcia C, Wartofsky L, Sgouros G, Van Nostrand D Local accession number: 2013_16 Add to cart (remove)
	12.	Characterization of Sialoadenitis (SA) after administration of continuous Sialogogues (SGs) during the day and night after 131I therapy (tx). MedStar authors: Acio, Elmo Burman, Kenneth D Garcia, Carlos Khorjekar, Gauri Kulkarni, Kanchan Orquiza, Michael D Schneider, Mark Wartofsky, Leonard Year: 2013 Citation: 2013/06/08/ Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Poster Presentation Local accession number: 2013_230 Add to cart (remove)
	13.	Characterization of sialoadenitis after administration of continous sialogogues during the day and night After 131 I therapy. MedStar authors: Acio, Elmo Burman, Kenneth D Garcia, Carlos Khorjekar, Gauri Kulkarni, Kanchan Orquiza, Michael D Schneider, Mark Wartofsky, Leonard Year: 2013 Citation: 2013/06/08/ Department: Department of Medicine/Endocrinology Department of Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Orquiza M, Khorjekar G, Schneider M, Kulkarni K, Garcia C, Acio E, Burman K, Wartofsky L Local accession number: 2013_165 Add to cart (remove)
	14.	Retrospective study of the utility of 18F sodium fluoride PET bone scans in patients with thyroid cancer with suspected bone metastases. MedStar authors: Burman, Kenneth D Garcia, Carlos O'Neil, Jeffrey Orquiza, Michael D Schneider, Mark Van Nostrand, Douglas Wartofsky, Leonard Wexler, Jason Year: 2013 Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Orquiza M, Schneider M, Garcia C, O'Neil J, Van Nostrand D, Wexler J, Burman K, Wartofsky L Local accession number: 2013_2 Add to cart (remove)
	15.	Retrospective study of the utility of 18F sodium fluoride PET bone scans in patients with differentiated thyroid cancer with suspected bone metastases MedStar authors: Burman, Kenneth D Garcia, Carlos O'Neil, Jeffrey Orquiza, Michael D Schneider, Mark Van Nostrand, Douglas Wartofsky, Leonard Wexler, Jason Year: 2013 Institution: MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Conference All authors: Orquiza M, Schneider M, Garcia C, O'Neil J, Van Nostrand D, Wexler J, Burman K, Wartofsky L Local accession number: 2013_8 Add to cart (remove)
	16.	Survival rate in differentiated thyroid cancer patients with bone metastases. MedStar authors: Atkins, Francis Burman, Kenneth D Khorjekar, Gauri R Kulkarni, Kanchan Moreau, Shari Orquiza, Michael H Van Nostrand, Douglas Wartofsky, Leonard Year: 2014 Citation: Unknown 2014 Jun 7 Department: Medicine/Endocrinology Medicine/General Internal Medicine Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Orquiza M, Van Nostrand D, Khorjekar G, Moreau S, Atkins F, Kulkarni K, Burman KD, Wartofsky L Local accession number: 2014.1_132 Add to cart (remove)
	17.	Characterization of sialoadenitis (SA) after administration of continuous sialogogues (SGs) during the day and night after 131I therapy (tx) MedStar authors: Acio, Elmo Burman, Kenneth D Garcia, Carlos Khorjekar, Gauri Kulkarni, Kanchan Orquiza, Michael D Schneider, Mark Van Nostrand, Douglas Wartofsky, Leonard Year: 2013 Institution: MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Conference All authors: Orquiza M, Khorjekar G, Schneider M, Kulkarni K, Garcia C, Acio E, Burman K, Wartofsky L, Van Nostrand D Local accession number: 2013_7 Add to cart (remove)
	18.	Altered taste after 131I therapy: the frequency, time of onset, severity, and duration MedStar authors: Acio, Elmo Burman, Kenneth D Garcia, Carlos Khorjekar, Gauri R Kulkarni, Kanchan Orquiza, Michael H Schneider, M Van Nostrand, Douglas Wartofsky, Leonard Year: 2014 Citation: Unknown 2014 Jun 7 Department: Medicine/Endocrinology Medicine/General Internal Medicine Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Orquiza M, Khorjekar G, Schneider M, Kulkarni K, Garcia C, Acio E, Burman K, Wartofsky L,Van Nostrand D Local accession number: 2014.1_134 Add to cart (remove)
	19.	Epiphora and xerophthalmia after 131I therapy: the frequency, time of onset, severity, and duration. MedStar authors: Acio, Elmo Burman, Kenneth D Garcia, Carlos Khorjekar, Gauri R Kulkarni, Kanchan Orquiza, Michael H Schneider, M Van Nostrand, Douglas Wartofsky, Leonard Year: 2014 Citation: Unknown 2014 Jun 7 Department: Medicine/Endocrinology Medicine/General Internal Medicine Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Orquiza M, Khorjekar G, Schneider M, Kulkarni K, Garcia C, Acio E, Burman K, Wartofsky L, Van Nostrand D Local accession number: 2014.1_133 Add to cart (remove)
	20.	Do negative 124I pretherapy positron emission tomography scans in patients with elevated serum thyroglobulin levels predict negative 131I posttherapy scans?. MedStar authors: Atkins, Francis Burman, Kenneth Garcia, Carlos Khorjekar, Gauri R Mete, Mihriye Moreau, Shari O'Neil, Jeff Orquiza, Michael H Van Nostrand, Douglas Wartofsky, Leonard PMID: 24820222 Citation: Thyroid. 24(9):1394-9, 2014 Sep. Institution: MedStar Health Research Institute MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Medline publication type: Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Atkins FB, Burman K, Garcia C, Khorjekar GR, Mete M, Moreau S, O'Neil J, Orquiza MH, Van Nostrand D, Wartofsky L DOI: http://dx.doi.org/10.1089/thy.2013.0713 Add to cart (remove)

Refine your search

Authors

Item types

Topics

Collections

Languages

Your search returned 20 results.